Status:
COMPLETED
18F-FDG Tomography and Labeled Leukocyte Scintigraphy
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Malignant Otitis Externa
Eligibility:
All Genders
18-80 years
Brief Summary
The study will aim to show that there is a superiority of 18F-FDG PET/CT compared to labeled leukocyte scintigraphy in patients with a malignant otitis externa.
Detailed Description
The management of malignant otitis externa (MEO) is a major issue in patients who are often polypathological and fragile. Appropriate antibiotic therapy must be started quickly after the diagnosis is ...
Eligibility Criteria
Inclusion
- patients with malignant otitis externa who received a 18F-FDG positron emission tomography and a labelled leukocyte scintigraphy
Exclusion
- patients who refuse to have their imaging data used
Key Trial Info
Start Date :
December 18 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 18 2023
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT05994768
Start Date
December 18 2020
End Date
October 18 2023
Last Update
November 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Verger Antoine
Vandœuvre-lès-Nancy, France, 54511